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ABSTRACT
The Effect of Early Environmental Manipulation on
Locomotor Sensitivity and Methamphetamine
Conditioned Place Preference Reward
by
Emily Hensleigh
Dr. Laurel Pritchard, Examination Committee Chair
Professor of Psychology
University of Nevada, Las Vegas
Early life stress has drastic effects on neurological development, affecting health and
well-being later in life. Instances of child abuse and neglect are associated with higher
rates of depression, risk taking behavior, and an increased risk of drug abuse later in life
(Chapman,D.P. 2004; Dube,S.R. 2003). This study used repeated neonatal separation of
rat pups as a model of early life stress. Rat pups were either handled and weighed as
controls or separated for 180 minutes per day during postnatal days 2-8. In adulthood,
rats were tested for methamphetamine conditioned place preference reward and
methamphetamine induced locomotor activity. Tissue samples were collected and
mRNA was quantified from the following brain regions: prefrontal cortex
(norepinephrine transporter), nucleus accumbens (dopamine transporter), and ventral
midbrain (cocaine-amphetamine regulated transcript). Results indicated rats given
methamphetamine formed a conditioned place preference, but there was no effect of early
separation or sex. Separated males showed heightened methamphetamine-induced
locomotor activity, but there was no effect of early separation for females. Overall
females were more active than males in response to both saline and methamphetamine.
This suggests early neonatal separation may differently affect methamphetamine-induced
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locomotor activity and methamphetamine reward. Additionally, these effects on
locomotor activity are likely sex-dependent.
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CHAPTER 1
INTRODUCTION
Early life stress, including child abuse or neglect, affects neurological development,
negatively impacting health and well-being later in life. Studies suggest child abuse and
neglect are associated with risk-taking behavior, increased risk of depression, and
increased vulnerability to drug abuse (Chapman et al., 2004; Dube et al., 2003).
Individuals who report early adverse experiences, such as abuse, are seven to ten times
more likely to report substance use compared to individuals without a history of early
adverse experiences. These individuals are also two to four times more likely to
experiment with illicit drugs at an early age compared to those without a history of early
adverse experiences. Finally, risk of developing an addiction drastically increases in
individuals with significant life histories of stress (Dube et al., 2003). Based on clinical
and animal studies, it is clear that early life stress causes neuroadapitve changes leading
to persistent negative behavioral and neurological effects. The following will review the
neurological correlates of stress, the relationship between stress and addiction, and the
developmental effects of early life stress.
Several effects occur as a result of activation of stress pathways, such as the HPA
axis. Minor stress, such as exercise, activates the stress response and results in slightly
elevated stress hormone levels. This activation result in healthful benefits for the
organism such as increased functioning of the HPA axis in response to a stressor.
However, prolonged activation of the stress response produces neurological adaptations
resulting in negative consequences such as prolonged elevated hormone levels in
response to a stressor and decreased negative feedback of the HPA axis (McEwen, 2007;
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Vazquez, 1998).The physiological stress response occurs after emotional or physiological
strain and is an adaptive mechanism necessary for survival. Physically, the stress
response prepares the organism to deal with an immediate threat by increasing heart rate
and respiration, constricting blood vessels, enhancing attention, and increasing energy
through glucose production. The paraventricular nucleus (PVN) of the hypothalamus and
norepinephrine neurons in the locus coeruleus regulate the stress response (Levine, 2000;
McEwen, 2007; Tsigos & Chrousos, 2002).
As suggested above, two main brain regions initiate and terminate the body‟s
biological response to stress, the paraventricular nucleus (PVN) of the hypothalamus and
norepinephrine neurons in the locus coeruleus. When an organism is under stress,
norepinephrine is released from cells bodies in the locus coeruleus, activating the flight or
fight response. Additionally, the paraventricular nucleus (PVN) of the hypothalamus
releases corticotropin releasing factor (CRF) and arginine-vasopressin. CRF, the primary
effector, in turn triggers the release of adrenocorticotropin hormone (ACTH) from the
anterior pituitary. ACTH circulates systemically to the adrenal glands, eventually leading
to the release of glucocorticoids, such as cortisol in humans and corticosterone in rats.
These hormones bind to glucocorticoid receptors throughout the body and brain.
Activation of glucocorticoid receptors in the hypothalamus and pituitary inhibits further
release of CRF and ACTH, respectively, thus terminating the stress response. These
events make up the hypothalamic-pituitary-adrenal (HPA) axis (Habib, Gold, &
Chrousos, 2001; Tsigos & Chrousos, 2002). Additionally, CRF binds to presynaptic
receptors located on norepinephrine neurons in the locus coeruleus, leading to inhibition
of norepinephrine release. Norepinephrine neurons also self regulate with α2-
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autoreceptors and receive input from several other systems including GABA, serotonin,
and opioid peptides. These components, the HPA-axis and norepinphrine functioning,
regulate the body‟s homeostatic stress response (Koob, 1999; Tsigos & Chrousos, 2002).
Homeostatic functioning also relies on daily circulating levels of CRF. In humans,
CRF and arginine-vasopressin maintain a daily rhythmic cycle, aiding in regulatory
behaviors such as sleep and feeding. Elevated blood concentrations of these hormones
occur during the onset of light (waking or morning) and gradually decrease throughout
the day, with low levels occurring at the onset of darkness (sleep or evening) (McEwen,
2007). Rats follow a similar diurnal pattern with elevated CRF levels occurring during
the onset of darkness (waking or evening) and gradually decreasing with low levels
occurring at the onset of light (sleep or morning) (Lightman et al., 2002).
The HPA-axis aides in regulating daily homeostasis; however overactivation due to
chronic stress leads to unfavorable consequences. Chronic stress increases the release of
CRF and arginine-vasopressin leading to possible alterations in the natural circadian
rhythm (Lightman et al., 2002; McEwen, 2007; Tsigos & Chrousos, 2002). Animal and
human studies suggest overactivation of the HPA-axis leads to increased risk of cardiac
disease, depression, type II diabetes, and drug abuse (McEwen, 2007). More specifically,
chronic stress enhances susceptibility to addiction in both human and animal studies. The
following paragraphs summarize supporting evidence for this claim.
Animals exhibit behaviors similar to relapse in humans. Recovering drug abusers
report drug relapse commonly co-occurring with major life stressors. Similarly, stress
alters drug self administration and drug reward in animal models (Koob, 2008; Sarnyai,
Shaham, & Heinrichs, 2001; Sinha, 2008; Tsigos & Chrousos, 2002). Rats self-
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administer more of a drug and acquire drug self administration more rapidly when
exposed to a stressor prior to training (Ahmed & Koob, 1997; Kitanaka, Kitanaka, &
Takemura, 2003; Pauly, Robinson, & Collins, 1993). Rats subjected to foot shock, a
known stressor, more readily self-administer cocaine (Ahmed & Koob, 1997). When
taught to lever-press for cocaine, animals extinguish lever-pressing when saline replaces
the drug. If given a priming injection of cocaine, the animal resumes lever-pressing
almost immediately, a phenomenon termed reinstatement. Experimental stressors
precipitate drug reinstatement without the need for a priming injection (Ahmed & Koob,
1997). The activation of the stress response via the HPA-axis affects many aspects of
drug self-administration and abuse. Neurological alterations in the HPA-axis after
repeated drug exposure further support this statement.
Neurological evidence indicates interactive effects between stress and drugs of abuse.
Acute administration of opiates, cocaine, alcohol, or amphetamine activates the HPA-axis
as well as the mesolimbic dopamine pathway (Majewska, 2002; Sarnyai et al., 2001).
Chronic administration of such drugs leads to over activation of the mesolimbic
dopamine pathway and the HPA-axis. This over activation may modify both systems,
contributing to withdrawal symptoms and drug relapse (Koob, 2008; Marinelli & Piazza,
2002).
Neurological alterations due to repeated exposure to drugs of abuse lead to
sensitization of certain behaviors in both humans and animal models. Sensitization refers
to the increased effect of a drug due to repeated use (Robinson & Berridge, 2001). In
humans, psychostimulants such as cocaine, amphetamine, or methamphetamine initially
increase activity levels. After chronic use of psychostimulants, several repetitive
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behaviors arise which may include sorting small objects, or „knick-knacking‟, and
repeatedly scratching or picking at the skin (Darke, Kaye, McKetin, & Duflou, 2008;
Winslow, Voorhees, & Pehl, 2007). In rodents, psychostimulants also initially increase
locomotor activity. After multiple doses, the initial locomotor activating effects of the
drug become sensitized and stereotyped behaviors become more prevalent (Vezina,
2004). These stereotyped behaviors include repeated rearing, constant head bobbing,
inappropriate gnawing, or excessive grooming (Randrup & Munkvad, 1974).
Sensitization, exhibited by these repetitive behaviors, is a long-lasting phenomenon.
After several months of drug cessation in rats, a challenge injection enhances stereotyped
behaviors, indicating enduring effects of repeated drug administration (Robinson &
Becker, 1986). In rodents and humans, drug effects become sensitized, such as the
locomotor activating effects of amphetamines, whereas other effects, such as euphoria,
become tolerant (Kitanaka et al., 2003). The neuroadaptations underlying sensitization
likely reflect the chronic, relapsing nature of addiction, which is further explained by the
Incentive-Sensitization Model of Addiction.
The Incentive-Sensitization Model of Addiction, proposed by Robinson and Berridge
(2001), suggests sensitization plays an important role in addiction. The model proposes
that repeated and persistent drug use leads to enduring neurological alterations, including
those involved in reward. The model further suggests brain reward systems become
hypersensitive to drugs of abuse and drug associated stimuli due to neuroadaptive
changes. These sensitized systems mediate the “wanting” component of drug reward as
opposed to the initial euphoric effects, or “liking” component, associated with the drug.
The mesotelencephalic dopamine system mediates the incentive motivational aspect or

5

“wanting” of a drug, whereas the euphoric effect of a drug, or “liking”, is mediated by
different neuronal systems. Since separate systems underlie “liking” and “wanting” it is
clear why repeated drug use sensitizes one behavior, but differently affects another
behavior. This model explains why the craving, or “wanting”, for a drug increases with
repeated use, but the euphoric effects, or “liking”, decreases with repeated use.
(Robinson & Berridge, 2001).
In addition, stress hormones, glucocorticoids such as cortisol or corticosterone, can
influence dopamine systems, regulating drug reward and craving. Glucocorticoids alter
dopaminergic transmission leading to increased drug-induced behavioral sensitization.
Artificial administration of glucocorticoids enhances amphetamine sensitization in rats,
whereas suppression of glucocorticoid secretion, via adrenalectomy, inhibits
amphetamine sensitization (Deroche et al., 1995; Pauly et al., 1993). Animals subjected
to experimental stressors further exhibit increased locomotor activity and stereotyped
behaviors induced by stimulants (Deroche et al., 1995; Majewska, 2002; Matuszewich &
Yamamoto, 2004). Based on the incentive sensitization model, stress may potentiate the
craving effects of drugs of abuse. Stressful early life experiences further illustrates the
enduring nature of sensitization.
Chronic stress during development can lead to enduring changes in stress systems.
In rodents, during the first two weeks after birth, the presence of the mother mediates the
function of the HPA-axis. Absence of the mother, or dam, promotes activation of the
HPA-axis and contact with the dam inhibits activation (De Kloet, Rosenfeld, Van
Eekelen, Sutanto, & Levine, 1988). During the critical first two weeks, prolonged
absence of the dam continually activates the HPA-axis, eventually leading to adaptations
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in the regulation of this system (Vazquez, 1998). Several animal models of chronic early
life stress attempt to elucidate the neural mechanisms that underlie such adaptations.
Extended separation of neonatal rat pups from the dam results in behavioral and
neurological deficits in adulthood. These animal models attempt to functionally represent
the neurobiological and behavioral consequences of early life stress, such as child
neglect.
Several rodent models have been used to reproduce the effects of early life stress.
The maternal deprivation model separates the entire litter of pups from the dam once for
24 hours during the first week after birth. Adolescent and adult rodents which have
undergone this procedure demonstrate deficits in both physical and cognitive
development compared to control groups (Lehmann, Russig, Feldon, & Pryce, 2002;
Rosenfeld, Wetmore, & Levine, 1992). The maternal separation model removes pups
from the dam and houses them together as an entire group. Neonatal isolation removes
pups from the dam and houses them individually until reunion with the dam. Separation
and isolation occurs for one to six hours daily during the first one to two weeks of
development. Control groups consist of either standard factory reared litters, which are
never handled except for cage changes, or briefly handled litters, which are handled for
approximately 15 minutes per day (Kalinichev, Easterling, Plotsky, & Holtzman, 2002;
Meaney, Brake, & Gratton, 2002). Social isolation also models early life stress but
occurs after weaning (or approximately 21 days of age), rather than during early postnatal
development. Socially isolated rats are housed in individual cages, while controls are
housed in pairs or small groups (Lapiz et al., 2003). All the aforementioned

7

manipulations result in behavioral and neurological deficits later in life, though the
effects vary, depending on which manipulation is applied.
Repeated maternal separation yields several behavioral deficits. In adulthood,
separated rats exhibit decreased struggle time in the forced swim task, suggesting
increased despair (Aisa, Tordera, Lasheras, Del Rio, & Ramirez, 2007). Separated rats
exhibit thigmotaxis and increased freezing behavior in an open field, suggesting fearful
behavior in response to novelty (Caldji, Francis, Sharma, Plotsky, & Meaney, 2000).
Similarly, compared to handled controls, separated rats exhibit hypoactivity in an open
field chamber, and later increased hyperactivity, indicating increased anxiety in a novel
environment (Kalinichev et al., 2002). Socially isolated rats also show an increased
activity level in a novel environment and augmented anxiety-like behavior similar to
separated animals (Lapiz et al., 2003). Additionally, separated rats display decreased
time in the open arms of an elevated plus maze, indicative of increased anxiety-like
behavior (Aisa et al., 2007). These studies illustrate chronic early life stress, induced by
separation or social isolation, results in depressive and anxiety-like behaviors later in life.
Control rats, standard factory reared, or handled rats also differ in behaviors in
adulthood, which may be mediated by the dam. Standard factory reared pups (not
handled for the first twenty one days of life) exhibit similar anxious behaviors compared
to separated animals (Lehmann et al., 1998). Brief handling of neonatal pups (15
min/day) results in opposite behavioral patterns compared to separated and standard
factory reared animals. As mentioned previously, separated animals show increased
exploratory or hyperactive behavior in a novel environment compared to briefly handled
controls (Kalinichev et al., 2002). The mother‟s behavioral response to separated and
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handled pups may mediate this difference. After brief handling of pups, dams engage in
increased maternal behavior when compared to dams of separated or standard factory
reared pups. Reunion of pups with the dam after a brief handling separation (15 min/day)
elicits a high degree of maternal behavior, such as arched back nursing and licking
(Pryce, Bettschen, & Feldon, 2001). This increased maternal behavior likely organizes
brain development in a way which promotes a less anxious behavioral phenotype.
Conversely, dams of standard factory reared pups do not exhibit robust maternal
behavior. In adulthood these pups demonstrate more anxious behavioral patterns
compared to handled controls (Levine, 1960). Long, repeated separations deprive pups
access to maternal care and result in comparable anxious behavioral patterns. Early
maternal care affects neurological development, and separating pups from the dam alters
patterns of maternal care.
Neurological alterations in HPA-axis functioning and dopamine systems likely
underlie behavioral effects of maternal separation observed in adulthood. Handled
controls and separated rats differ in their physiological responses to stress (Ladd, Huot,
Thrivikraman, Nemeroff, & Plotsky, 2004; Plotsky & Meaney, 1993). Adult separated
rats show elevated levels of adrenocorticotropin hormone (ACTH) and corticosterone in
response to a brief stressor (Aisa, Tordera, Lasheras, Del Rio, & Ramirez, 2008;
Lippmann, Bress, Nemeroff, Plotsky, & Monteggia, 2007). Importantly, handled
controls and separated animals do not differ in basal diurnal patterns of ACTH,
suggesting separated animals exhibit a potentiated stress response. After footshock, a
known stressor, separated animals show prolonged elevation of glucocorticoid blood
levels suggesting prolonged activation of the HPA-axis (Aisa et al., 2007; Aisa et al.,
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2008; Ladd, Owens, & Nemeroff, 1996). Heightened and prolonged stress response also
coincides with alterations in the HPA-axis negative feedback loop. Plotsky et al. (2005)
subjected rats to two weeks of postnatal separation. In adulthood, these rats exhibited
increased CRF mRNA levels in the paraventricular nucleus, central nucleus of the
amygdala, locus coeruleus, and bed nucleus of the stria terminalis, suggesting
compensatory mechanisms for elevated response to a stressor (Plotsky et al., 2005).
Separated animals also exhibit reduced negative feedback of the HPA-axis regulated by
glucocorticoid receptors, likely mediated by decreased glucocorticoid receptor density in
the hippocampus (Ladd et al., 2004). Early life stress negatively impacts the stress
response by reducing the effectiveness of the negative feedback shut-off loop.
Chronic stress early in development also alters the mesolimbic dopamine system,
important in the rewarding properties of drugs of abuse (Arborelius & Eklund, 2007;
Brake, Zhang, Diorio, Meaney, & Gratton, 2004). Separated animals show decreased
dopamine transporter count in the nucleus accumbens and show elevated dopamine levels
in the striatum after a stressor (Matthews, Dalley, Matthews, Tsai, & Robbins, 2001;
Meaney et al., 2002). These alterations likely influence susceptibility to the effects of
drugs of abuse.
Furthermore, repeated early life stress alters neurological systems likely underlying
sensitization and rewarding properties of psychostimulants. Separated rats acquire
cocaine self administration more rapidly and self administer cocaine at a lower dose
compared to briefly handled controls (Kosten, Miserendino, & Kehoe, 2000; Moffett et
al., 2006). Separated animals also exhibit increased sensitivity to the effects of an acute
challenge injection of cocaine and an acute injection of amphetamine (Kikusui et al.,
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2005; Matthews, Hall, Wilkinson, & Robbins, 1996). Compared to non handled controls,
maternally separated rats exhibit increased sensitivity to the reward-enhancing effects of
amphetamine in adulthood (Der-Avakian & Markou, 2010). However, no effects of
amphetamine locomotor sensitization were found in separated or isolated rats (Brake et
al., 2004; Weiss et al., 2001). Additionally, no effects of amphetamine locomotor
sensitization across doses were found in neonatally separated rats (Hensleigh, Smedley,
& Pritchard, 2010). These findings suggest early life stress may alter brain systems
increasing vulnerability to drug reward in adulthood. Similarly, early life stress likely
affects similar systems which may or may not lead to drug-induced locomotor
sensitization.
Early environmental stress likely alters the rewarding properties of psychostimulants,
such as cocaine and amphetamine, however the effect of early environmental stress on
methamphetamine needs to be better characterized. Structurally and mechanistically,
amphetamine and methamphetamine are similar; although differences exist between the
two substances. In humans, different abuse patterns result in varying neurological
effects. Amphetamine is typically obtained from prescription drugs and administered
orally in single large doses. Illicit manufacturing of methamphetamine results in varying
potencies, consumed typically by smoking dissolved crystals. Individuals who abuse
methamphetamine administer the drug in a binge pattern with multiple high doses of the
drug consumed over a few hours or days (Winslow et al., 2007).
The growing estimates of methamphetamine abuse increases demand for improved
research. An estimated 731,000 individuals twelve or older (0.3 percent of the
population) reported using methamphetamine at least once within the past year. Reports
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of methamphetamine abuse remain elevated relative to 30 years ago, requiring the need
for improved understanding of this drug (NIDA, 2008).
Methamphetamine is inexpensive to manufacture and relatively simple to obtain.
Mass production of methamphetamine occurs by obtaining pseudophedrine from several
over-the-counter drugs (Winslow et al., 2007). Increased regulations on the purchase of
pseudophedrine-containing drugs have been implemented in an attempt to decrease the
illegal production of methamphetamine. Regardless, methamphetamine production and
illicit sales continue throughout the United States and other countries (Cunningham &
Liu, 2003; Winslow et al., 2007). Typical administration of methamphetamine occurs
through smoking crystals, which allows for rapid behavioral and neurological effects.
Acute behavioral effects of methamphetamine result from increased release of
monoamines and include euphoria, enhanced libido, elevated energy, and bruxism
(grinding teeth). Many of these effects contribute to methamphetamine‟s addictive
properties. Physiological effects result from systemic release of adrenaline (epinephrine)
and include increased heart rate, increased blood pressure, and hyperthermia (Kish, 2008;
Winslow et al., 2007).
In vitro and in vivo studies shed light on the pharmacological mechanisms of
psychostimulants. Amphetamines enter the terminal buttons through the membrane
transporters to exert their stimulant effects. Relative affinities for methamphetamine and
amphetamine are highest at the norepinephrine transporter, followed by the dopamine
transporter, and finally the serotonin transporter. Methamphetamine exerts a greater
effect (potency) at the serotonin transporter compared to amphetamine (Han & Gu, 2006;
Kuczenski, Segal, Cho, & Melega, 1995). Inside the terminal, methamphetamine
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liberates monoamines from vesicles releasing them into the cytoplasm. Reversal of the
membrane transporter by methamphetamine pumps the newly dumped monoamines out
of the terminal button into the synapse. Additionally, methamphetamine and
amphetamine inhibit monoamine oxidase, slowing the breakdown of the available
monoamines (Fleckenstein, Volz, Riddle, Gibb, & Hanson, 2007). The perceived
rewarding effects relate to the dopamine transporter, although recent studies suggest an
important role for norepinephrine transporters in the rewarding properties of stimulants
(Fleckenstein et al., 2007; Schank et al., 2006; Sofuoglu & Sewell, 2009; Ventura, Cabib,
Alcaro, Orsini, & Puglisi-Allegra, 2003).
Several acute neurochemical effects occur after methamphetamine administration. In
rats, acute administration of methamphetamine results in elevated levels of monoamines
in the striatum (Fleckenstein, Metzger, Wilkins, Gibb, & Hanson, 1997; Haughey,
Brown, Wilkins, Hanson, & Fleckenstein, 2000). Methamphetamine also rapidly
regulates dopamine and norepinephrine transporters. Acute methamphetamine injection
rapidly down regulates expression of the dopamine transporter in vivo and in vitro. This
effect is reversible and occurs at high doses (Zahniser & Sorkin, 2004).
Methamphetamine acutely decreases clearance of dopamine in the synaptic cleft by
inhibiting reuptake through the dopamine transporter (Goodwin et al., 2009; Zahniser &
Sorkin, 2004). These short term effects can lead to several long term changes with
continual methamphetamine administration.
Long term methamphetamine abuse potentially leads to prolonged neuorotoxic
damage in dopamine systems. Neurotoxicity characteristically occurs after multiple
consecutive doses or a single high dose of methamphetamine. Clinical studies and
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animal models of methamphetamine abuse exhibit neurotoxic damage. Individuals who
abuse methamphetamine follow a characteristic dosage pattern, where methamphetamine
administration occurs in „runs‟. This abuse pattern consists of short methamphetamine
binges taken at multiple points over hours or days. Rats given a similar pattern of
methamphetamine administration exhibit reduced dopamine levels and decreased
dopamine transporter density in the nigrostriatal dopamine pathway (Hanson, Rau, &
Fleckenstein, 2004; Kita, Wagner, & Nakashima, 2003; Segal, Kuczenski, O'Neil,
Melega, & Cho, 2005). Imaging studies show decreased dopamine transporter density in
the nucleus accumbens, prefrontal cortex, and caudate putamen of chronic
methamphetamine abusers. Decreased dopamine transporter density furthermore suggests
dopamine terminal damage associated with motor impairment and cognitive deficits in
chronic methamphetamine abusers (Chang, Alicata, Ernst, & Volkow, 2007; Sekine et
al., 2001; Wilson et al., 1996). These studies suggest chronic administration of
methamphetamine can lead to prolonged alterations in monoamine systems.
Dopamine presumably underlies damage and behavioral effects of methamphetamine
toxicity. Mainly, the dopamine transporter mediates the neurotoxic effects of
methamphetamine. Substances which block the dopamine transporter, such as cocaine,
show neuroprotective effects against methamphetamine toxicity. These neuroprotective
effects occur even if administration of dopamine transporter blockers occurs several
hours after neurotoxic doses of methamphetamine (Marek, Vosmer, & Seiden, 1990).
Norepinephrine also allegedly mediates the neurotoxic damage of methamphetamine
induced dopamine release. Blocking norepinephrine release pharmacologically, by
lesions, or by genetic deletion results in increased dopamine release in the striatum,
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enhanced methamphetamine induced stereotyped behaviors, and enhanced markers of
neurotoxicity (Weinshenker et al., 2008). This suggests that without norepinephrine
present, increased dopamine is released leading to detrimental neurotoxic effects.
Chronic methamphetamine administration results in neurotoxicity, likely mediated by
high levels of dopamine, leading to lasting injury in dopamine systems.
The majority of injury caused by methamphetamine occurs within dopamine systems;
however deficits also occur in other monoamine systems. Methamphetamine abusers
exhibit decreased serotonin transporters and vesicular monoamine 2 transporters in
subregions of the striatum (Kita et al., 2003). Similarly, rats exhibit decreased serotonin
transporter density and serotonin depletion after neurotoxic doses of methamphetamine
(Friedman, Castaneda, & Hodge, 1998). Chronic methamphetamine administration in
rats also results in damage to serotonergic terminals in the forebrain (Marshall, Belcher,
Feinstein, & O'Dell, 2007). After an increasing dose regimen of methamphetamine, a
challenge dose results in norepinephrine and serotonin depletion in the hippocampus,
striatum, and cortex along with the marked depletions of dopamine observed in the
striatum (Graham, Noailles, & Cadet, 2008).

Methamphetamine neurotoxicity involves

depletions throughout several neurotransmitter systems.
Animal models can allow us to elucidate neurological factors of addiction and
contributing factors of drug abuse vulnerability otherwise difficult to tease out in the
clinical population. Ethical constraints prohibit administration of illicit psychoactive
drugs to human subjects. Beyond imaging techniques, studying the neurochemical effects
of psychoactive drugs in living human subjects remains a challenge. Similarities across
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mammalian species allows for understanding predispositions to addiction and identifying
mechanisms which otherwise could not be elucidated in humans.
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CHAPTER 2
RESEARCH QUESTIONS
This study asked two main research questions. First, does prolonged stress during
development affect sensitivity to the locomotor effects and rewarding properties of
methamphetamine in adulthood? To answer this question, this study employed the use of
an animal model of early life stress. Separated and handled control rats were tested for
locomotor sensitization and conditioned place preference. Conditioned place preference
was used as a measure of the rewarding properties of methamphetamine. Control and
separated rats were given injections of saline and methamphetamine that were repeatedly
paired with distinct environments. A final place preference test determined the rewarding
properties of methamphetamine (see materials and methods for a more in depth
discussion of procedures). It was predicted that early life stress would increase the
rewarding properties and locomotor activating effects of methamphetamine. Therefore,
separated subjects were hypothesized to spend more time in the drug paired chamber
compared to handled controls and exhibit heightened locomotor activity in response to
methamphetamine.
The second research question consisted of: do neurobiological mechanisms involving
brain monoamine systems underlie the behavioral effects of early separation on
methamphetamine sensitivity? To get at this question, expression of messenger RNA for
the following gene targets was quantified using RT-PCR: the dopamine transporter
(DAT), the norepinephrine transporter, and the neuropeptide Cocaine-Amphetamine
Regulated Transcript (CART).
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For this study, dopamine transporter mRNA was quantified in the nucleus
accumbens. Reduced levels of the dopamine transporter were found in the nucleus
accumbens of separated rats (Meaney et al., 2002). The dopamine transporter (DAT) is
important for stimulant addiction and is regulated immediately and long-term by
stimulants (Haughey et al., 2000; Zahniser & Sorkin, 2004). Therefore, separated
animals were hypothesized to have decreased DAT levels in the nucleus accumbens.
For this study, norepinephrine transporter mRNA was quantified in the prefrontal
cortex. Alpha 2 adrenergic receptor density was greater in locus coeruleus of handled
animals compared to separated animals in adulthood, suggesting early separation affects
norepinephrine systems (Liu, Caldji, Sharma, Plotsky, & Meaney, 2000). Because α2
receptors function as autoreceptors, reduced expression in separated rats relative to
handled controls suggests a deficit in noradrenergic regulation in separated rats.
Norepinephrine transporter density was thought to have served as an adaptive mechanism
to compensate for enhanced norepinephrine due to reduced autoreceptor activity.
Increased levels of membrane NETs were found in rat prefrontal cortex after chronic cold
stress (Miner et al., 2006). Therefore it was hypothesized that chronic early life stress
would to result adaptive mechanisms leading to increased NET in the prefrontal cortex.
Lastly, Cocaine-Amphetamine Regulated Transcript (CART) was quantified in the
ventral midbrain. CART is a peptide involved in regulatory behaviors, such as feeding
and stress, and is further thought to be involved in the rewarding and reinforcing
properties of psychostimulants. CART was named because mRNA of the peptide was
upregulated after administration of cocaine and amphetamine ( Douglass, McKinzie, &
Couceyro, 1995; Jaworski & Jones, 2006; Vicentic & Jones, 2007). CART has been
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localized in numerous areas of the brain including the hypothalamus, mesolimbic
dopamine system, pituitary, and hindbrain (Vicentic & Jones, 2007). An increase in
CART expression in the hippocampus was observed after chronic stress (Hunter et al.,
2007). Injection of CART into the ventral tegmental area promoted locomotor behavior
and potentiated conditioned place preference (Kimmel, Gong, Vechia, Hunter, & Kuhar,
2000). Suggesting possible similar underlying systems involved in cocaine and
amphetamine induced locomotor activity. CART containing neurons in the VTA also
synapse on dopamine containing neurons, which could play a role in mediating
locomotor activity and CPP (Dallvechia-Adams, Kuhar, & Smith, 2002). The effects of
chronic early life stress and methamphetamine dosing on CART expression were
previously unknown. For the current study, CART mRNA was quantified in the ventral
midbrain, which included the ventral tegmental area and substantia nigra.
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CHAPTER 3
METHODOLOGY
Subjects
This was a 2 sex (male x female) x 2 condition (control x separated) x 2 drug (saline x
methamphetamine) factorial design. Sixteen female and sixteen male Long-Evans rats
were obtained from Charles River Inc. (Massachusetts) and used as breeders. Subjects
had one week to habituate to the facility before being paired for breeding (see section on
breeding procedures). Dams provided 73 offspring (34 males, 39 females) used for final
analyses. Animals were kept on a 12:12 hour light/dark schedule with lights on at 0730
hrs. All animals were housed in polypropylene tub cages lined with corn cob bedding
and had free access to food and water. Females were housed in pairs until breeding, after
which each dam was housed singly. Males used for breeding were singly housed for the
duration of the experiment, and cage changes occurred biweekly. Experimental
manipulations took place between 0800 hrs and 1700hrs. All procedures were performed
in accordance with the National Research Council Guide for the Care and Use of
Laboratory Animals and approved by the Institutional Animal Care and Use Committee
at University of Nevada Las Vegas.
Breeding Procedures
One male and one female were placed together in a hanging wire cage for no more
than five days. Fertilization was designated by the presence of a vaginal plug. After
confirmation of a vaginal plug, females were removed and housed singly in
polypropylene cages. If no plug was identified after five days, pairs were separated and
females were singly housed and monitored for pregnancy.
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Maternal Separation Procedure
The day of birth was designated post natal day (PND) 0 and litters were left
undisturbed on this day. On PND 1, the dam was removed and pups were sexed and
either culled or fostered to achieve roughly equal litter sizes and sex ratios. Separation
and control procedures occurred on PND 2-8. Control litters were removed from the
dam, transported to the testing room, and individually weighed. Individual pups were
identified by number markings using a non-toxic pen. After all pups were weighed, the
pups were rolled in soiled home cage bedding and returned to the dam. Control
procedure lasted approximately 10-15 minutes. Separated (S) animals were removed
from the dam, transported to the testing room, and individually weighed. Each pup was
placed in an individual plastic cup covered with an air-vented lid for three hours.
Temperature was monitored and kept at that of the nest, approximately 30 degrees
Celsius, by use of a heating pad. Two to four pups from each litter were left with the
dam during separation to decrease stress on the mother. After three hours, separated pups
were transported back to the animal housing room, rolled in soiled cage bedding, and
returned to the dam, where they remained undisturbed until the next day. Beginning on
post natal day (PND) 9, all litters were left undisturbed, except for weekly cage changes.
On PND 21, all pups were weaned from the mother and pair housed by same sex until
behavioral testing began on PND 60.
Behavioral Testing
A 70cm X 30cm X 30cm chamber equipped with three separate compartments was
used to assess conditioned place preference (CPP). Each side compartment measured
29.7 x 28.7 x 11.8 cm³, had a distinct wall color (black or white), and distinct floor
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texture (bars or grid). Side compartments had a door with a removable sliding panel
leading into the center compartment. The middle compartment measured 9.8 x 28.7 x
11.8 cm³ and was gray with a smooth floor. The chamber was equipped with a fan for
ventilation and noise cover, an adjustable LED light, and a 7 x 15 photobeam grid
tracking system located 2.5 cm above the floor of the chamber. Data from photobeam
breaks were transferred into a Dell computer running a program (Motor Monitor by
Kinder Scientific) that measured time spent in each compartment and activity level by
total amubulations. One ambulation was defined as two adjacent, consecutive beam
breaks.
Methamphetamine hydrochloride was obtained from Sigma-Aldrich (St. Louis, MO)
and dissolved in sterile 0.9% saline at a concentration of 1.0 mg/ml (calculated based on
salt weight). Injections were given subcutaneously in a volume of 1.0 ml/kg of body
weight, resulting in a methamphetamine dose of 1.0 mg/kg. This dose was selected based
on previous studies demonstrating robust locomotor activation and conditioned place
preference in rats at a similar dose (Shimosato & Ohkuma, 2000; Zakharova, Leoni,
Kichko, & Izenwasser, 2009)
Testing began between PND 58-64 and lasted 10 days. Subjects were brought to the
testing room to habituate for 30 minutes before testing each day. Subjects were placed in
the center compartment of the conditioned place preference chamber with both doors
open and allowed to explore the entire chamber for 30 minutes. Animals were randomly
assigned as saline or methamphetamine group. The saline group consisted of both
separated and handled animals and received saline injections paired with both chambers.
An initial chamber preference was determined for both groups by analyzing the amount
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of time spent in each chamber during the habituation day. If a preference existed,
methamphetamine was paired with the non-preferred chamber and saline was paired with
the preferred chamber. For the saline group, the non-preferred chamber randomly
designated as the „drug‟ chamber and used for comparison against experimental animals.
If no preference existed, the chambers were randomly assigned as drug or saline paired
chambers.
All injections occurred 15 minutes prior to being placed in the chamber. The day after
chamber habituation, subjects were injected with saline and placed in the previously
assigned saline-paired chamber for 30 minutes. On the following day, animals were
transported to the testing room and given an injection of saline or methamphetamine
(1.0mg/kg) and placed in the drug-paired chamber for 30 minutes. Saline and
methamphetamine injections occurred on alternating days until four pairings with each
compartment (8 days total) occurred. Control animals received saline injections paired
with alternating chambers every day. Ambulation data was also collected on these days.
The day after the last pairing subjects were given no injection and placed in the CPP
chamber with both doors open for 30 minutes. Ambulatory data was collected during this
time and examined using three different zones (saline paired chamber, center chamber,
and meth paired chamber). After 30 minutes, animals were returned to their cages and
left undisturbed in the animal colony for 24 hours until sacrifice, dissection, and tissue
collection. For every session, each rat was tested in the same apparatus and at
approximately the same time of day. Dependent variables for each session included total
ambulations (locomotor activity) and time spent in each compartment. A place
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preference was determined if the animal spent significantly more time in the drug paired
chamber compared to the saline paired chamber.
Tissue Collection
Twenty four hours after the final test day, animals were euthanized by an overdose of
Euthasol (pentobarbital sodium and phenytoin sodium) and decapitated. Brains were
immediately removed and chilled in 0.9% saline for five minutes. With the aid of a
rodent brain matrix, the following structures were dissected out: prefrontal cortex,
nucleus accumbens, and ventral midbrain (a single block containing ventral tegmental
area and substantia nigra).
Tissue was placed in individual plastic tubes, immediately frozen on dry ice, and kept
in -80˚ C storage until mRNA quantification. Total RNA was isolated by manufacturers
instructions using an E.Z.N.A. Total RNA Kit (OMEGA). Briefly, tissue samples were
homogenized in 1 mL of RNA Solv and 20 µl 2-mercaptoethanol (30 mg of tissue) and
incubated for 5 minutes at room temperature. 200µl of chloroform was added and
homogenate was incubated at room temperature for 2-3 minutes followed by
centrifugation at 12,000 x g at 4°C for 15 minutes. The upper phase was transferred and
combined with equal volume of 70% ethanol. Sample was applied to a spin column and
centrifuged at room temperature at 10,000 x g for 1 minute. Samples were washed with
500µl of RNA Wash Buffer I, centrifuged at room temperature at 10,000 x g for 1
minute, and flow through was discarded. Samples were washed twice more with 500µl
of RNA wash buffer II, centrifuged at room temperature at 10,000 x g for 1 minute.
Sample columns were centrifuged at maximum speed for 2 minutes at room temperature.
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RNA was eluted in 55µl of nuclease free water by centrifuging at 10,000 x g for 2
minutes. RNA was kept at -80°C until RT-PCR.
Sample total RNA concentration and integrity was determined by A260 measurement.
mRNA was reverse-transcribed and amplified using a qScript One-Step SYBR Green
qRT-PCR kit (Quanta). Briefly, samples were thawed on ice and diluted to equal
concentrations (50ng/µl). Reaction mix contained the following volumes per well: 25µl
One-Step SYBR Green Master Mix, 3 µl forward primer, 3 µl reverse primer, 8 µl
Nuclease free water, 1 µl qScript One-Step RT, and 10 µl RNA template. Samples were
assayed in duplicate in 96-well plates using an iCycler (Biosciences). Quantification was
achieved by normalizing the target mRNA to the house keeping gene glyceraldehyde-3phosphate dehydrogenase (GAPDH). A standard curve was calculated using seven serial
dilutions (800ng-12.5ng for DAT, CART, and GAPDH, 400ng-6.25ng for NET) of total
RNA. The target quantity in experimental samples was normalized to GAPDH and
compared against the handled, saline group. Final values were analyzed using a between
subjects ANOVA.
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CHAPTER 4
RESULTS
Locomotor Activity and Conditioned Place Preference
To determine a chamber preference, a ratio score was calculated by subtracting the
amount of time spent in the drug paired chamber on day ten from the drug paired
chamber on day one and dividing by time spent in drug paired chamber on day 10 ((Time
day10 – Time day1)/TimeDay10). Data was analyzed using a 2 sex (male x female) x 2
condition (control x separated) x 2 drug (saline x methamphetamine) between subjects
ANOVA. There was a significant effect of drug (F(1,72) = 14.45, p<0.001) with
methamphetamine animals spending more time in the drug paired chamber. There was no
significant effect of condition (F(1,72) = 1.56, p>0.05) or sex (F(1,72) = 0.803, p>0.05)
or significant interactions for time spent in the drug paired chamber (Supplementary
figure 1).
Two mixed model ANOVAs were used to analyze total ambultions on drug paired
days and saline paired days for subjects in the methamphetamine group. Day was the
within subjects factor (day 2, 4, 6, 8 for saline pairings and 3,5,7,9 for drug pairings) with
condition (control x separated) and sex (male x female) as between subjects factors.
Results for the drug paired days indicated no significant effect of days (F(3,30) = 2.75,
p>0.05) and a significant effect of sex (F(1,32) = 11.43, p<0.001) with females exhibiting
higher locomotor activity. Condition was approaching significance (F(3,32) = 3.57,
p=0.068) with separated animals exhibiting higher locomotor activity. There was no sex x
condition interaction (F(1,32) = 0.054, p>0.05). Results for the saline paired days
indicated a similar trend with no effect of day (F(3,30) = 1.12, p>0.05) and a significant
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effect of sex (F(3,32) = 13.62, p<0.001) with females exhibiting higher locomotor
activity. There was no significant effect of condition (F(3,32) = .84, p>.05) and no
significant sex x condition interaction (F(1,32 = .61, p>.05). (Supplementary figures 2 &
3).
RT-PCR
There was no significant effect in the ventral midbrain (CART) of condition
(F(1,54) = 1.41, p>.05) or drug (F(1,54) = 0.06, p>.05) or sex (F(1,54) = 1.60, p>.05).
There were no significant interactions. There was no significant effect in the prefrontal
cortex (NET) of condition (F(1,72) = 0.06, p>.05) or drug (F(1,72) = 0.32, p>.05) or sex
(F(1,72) = 1.63, p>.05). There were no significant interactions. There was no significant
effect in the nucleus accumbens (DAT) of condition (F(1,35) = 1.28, p>.05) or drug
(F(1,35) = 0.43, p>.05) or sex (F(1,35) = 0.27, p>.05). There were no significant
interactions. (Table 2).
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CHAPTER 5
DISCUSSION
Adverse early childhood experiences, or early life stress, increases the risk for
human substance use and abuse. Self report data indicate the degree of adverse
childhood experiences correlates with risk for drug abuse. A high degree of reported
adverse childhood experiences correlates with increased likelihood of beginning drug use
(Dube et al., 2003). Animal models furthermore indicate early life stress alters drug
related behaviors in adulthood. Compared to handled controls, separated animals exhibit
increased sensitivity to cocaine (Brake et al., 2004). Separation and other early life
stressors also potentiate the rewarding properties of alcohol, morphine, and cocaine in
rodents (Vazquez, Giros, Daugé, 2006; Moffett, Vicentic, Kozel, Plotsky, Francis, Kuhar,
2007). This suggests early life stress alters neurological stress systems leading to long
lasting susceptibility to drugs of abuse (Caldji et al., 1998; Liu et al., 1997; Meaney and
Szyf, 2005). Alterations of these stress systems likely interact differently with varying
drug of abuse. This study sought to determine the effect of early life stress on
methamphetamine reward and locomotor activity, as well as to determine contributing
neurological factors.
The results of this study indicated subjects exposed to methamphetamine formed
a conditioned place preference for the drug paired chamber. Increased preference for the
drug paired chamber is a measure of the reinforcing value of a drug and correlates with
abuse liability in humans (Bardo & Bevins, 2000). Early drug exposures result in a
pleasurable state and these pleasurable feelings reinforce drug taking behavior. Repeated
exposure to a drug results in prolonged neurological changes perpetuating far beyond
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drug cessation. These neurological changes lead to drug seeking behavior long after
recovery in both humans and animals (Nestler, 2001; Robbinson & Berridge, 2001).
Time spent in the drug paired chamber is conceptualized as an indirect measure of drug
seeking, suggesting rats that received repeated methamphetamine pairings exhibited a
place preference for the drug paired chamber.
Separated and control rats did not differ in the magnitude of methamphetamine place
preference. Previous findings indicate maternally separated rats show increased
vulnerability for rewarding properties of cocaine, alcohol, and morphine using self
administration paradigms (Vazquez, Giros, Daugé, 2006; Moffett, Vicentic, Kozel,
Plotsky, Francis, Kuhar, 2007). However, conditioned place preference reward remains
less characterized in maternal separation. Similar to the results of this study, Faure,
Stein, and Daniels (2010) reported no effect of maternal separation for methamphetamine
conditioned place preference (CPP). Several procedural differences exist between the
current study and that of Faure, Stein, and Daniels (2010). In both studies male and
female pups were separated for three hours per day. The current study separated pups
individually during post natal days (PND) 2-8 and tested male and female adult rats.
Faure, Stein, and Daniels however, separated pups as a group during PND 2-14 and only
tested male adult rats. The procedural discrepancies however still resulted in the same
behavioral outcome for methamphetamine CPP. This suggests early life stress does not
alter methamphetamine CPP in adulthood.
These results however, do not generalize to other drugs of abuse. Campbell and
Spear (1999) showed fifteen minute daily isolations decreased amphetamine conditioned
place preference compared to non handled controls. This suggests early brief isolations
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decrease the rewarding properties of amphetamine in adulthood. The current study
compared fifteen minute handled controls against three hours of separation and did not
find an effect on conditioned place preference. Based on Campbell and Spear‟s results,
the addition of a nonhandled condition may lead to significant differences in
methamphetamine conditioned place preference. Additionally, animals separated for
three hours per day during post natal day 1-14 exhibited greater and prolonged morphine
conditioned place preference relative to standard factory reared animals (Vazquez, PenitSoria, Durand, Besson, Giros & Daugé, 2005; Vazquez, Weiss, Giros, Martes, & Dauge,
2007). These results suggest early stress increases the rewarding properties of opiates.
The disparity between the aforementioned studies and the current findings may be a
result of several factors. The effect of stress on drug reward varies depending on drug
class, type of stress, and drug reward measure (Lu, Shepard, Hall, & Shaham, 2003).
This suggests the disparity between this study and previous significant findings may be a
result of pharmacological differences. Methamphetamine is reported as being more
potent in human users and exerts greater effects on the dopamine transporter in vitro and
in vivo (National Institute on Drug Abuse, 2006; Goodwin et al., 2009). Higher potency
of methamphetamine likely leads to greater aversive properties, which may explain why a
difference in methamphetamine place preference was not seen in separated, compared to
control animals.
Additionally, procedural differences across early life stress paradigms may account
for the disparities among studies. The length of neonatal separation as well as the group
used as comparison controls may underlie these differences. Two weeks of neonatal
separation may have a greater impact on conditioned drug reward, as observed with
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morphine (Vazquez et al., 2005), compared to one week of neonatal separation employed
in the present study. However, Faure, Stein, and Daniels (2010) separated pups for two
weeks and did not find an effect on methamphetamine conditioned place preference,
suggesting length of separation may not mediate these effects.
Along with drug reward, discrepancies in psychostimulant-induced locomotor
sensitivity also occur among neonatal separation paradigms. Kikusui, Faccidomo, and
Miczek (2005) found increased cocaine locomotor sensitivity in maternally separated rats
compared to handled controls. Conversely, Mathews et al. (2004) reported maternally
separated animals had a decreased locomotor response to an acute injection of
amphetamine. The current study indicated a trend towards increased locomotor activity
in response to methamphetamine injections for separated male animals. Previous studies
measured locomotor activity in an open field whereas this study measured locomotor
activity in the context of conditioned place preference. The association of the drug and a
particular environment (as in conditioned place preference) may differently affect
locomotor activity compared to an open field. Future studies should examine the effects
of early life stress on methamphetamine locomotor activity in the context of an open
field. Additionally, locomotor activity should be examined over a broad range of doses
of methamphetamine and with prolonged exposure to methamphetamine. From these
types of studies, it can be distinguished whether early life stress affects locomotor
sensitivity in a dose dependent manner and whether methamphetamine sensitization is
altered by early life stress.
Maternal behavior likely mediates the effects of early maternal separation as dams
spend more time licking and grooming when pups are returned after separation (Kosten
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& Kehoe, 2010). Most studies use artificially-created test all-male litters and remove all
the pups from the dam for the entire length of separation (Mathews et al., 1996; Ladd et
al., 1996; Brake et al., 2004). The current study left two to four pups with the dam during
separation to reduce the stress experienced by the dam. This may have decreased the
amount of time the dam spent licking and grooming the pups after separation leading to a
blunted effect on drug reward in adulthood. Future studies should determine the extent to
which the dams behavior mediates the effects of early separation.
Furthermore, varying patterns of maternal care likely contribute to alterations in
neurological systems leading to variations in adult drug related behaviors. Drugs of
abuse act on dopamine systems; in particular psychostimulants exert their mechanism of
action on the dopamine transporter (DAT). Previous studies found that maternally
separated animals exhibit decreased DAT levels in the nucleus accumbens using
quantitative receptor autoradiography (Brake et al., 2004; Meaney et al., 2002). The
decreased levels observed in Brake et al. (2004) may not be reflected in DAT mRNA
levels in separated animals, as occurred in the current study. DAT levels appear to
mediate the effects of drug reward whereas dopamine receptors may mediate locomotor
activity. Dopamine D1, D2, and D3 receptors mediate psychostimulant locomotor
activity (Depoortere, 1999), and these receptors are also altered by maternal separation
(Brake et al., 2004; Vazquez et al., 2007). The current study found no indications of
differences in methamphetamine reward but did find an effect of increased
methamphetamine locomotor activity in separated males. Therefore, dopamine receptors
would likely be altered rather than the dopamine transporter.
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No significant changes were found in norepinephrine transporter (NET) expression in
the prefrontal cortex. Lui et al. (2000) found decreased α2 adrenergic receptor density in
the locus coeruleus of separated animals relative to handled controls. Additionally,
decreased norepinephrine levels were found in the cingulate cortex of separated animals
relative to non handled controls (Arborelius & Eklund , 2007). These studies suggest
early separation alters brain norepinephrine systems but likely through mechanisms other
than prefrontal NET expression.

Additionally, decreased norepinephrine levels in the

frontal cortex were found 24 hours after eight days of escalating methamphetamine self
administration but returned to normal after 24 hours of cessation of methamphetamine
(Krasnova et al., 2010). Because of the short-lasting effects of acute methamphetamine
on norepinephrine systems, alterations in NET would not likely occur without prolonged
administration of methamphetamine. The moderate (1.0mg/kg), intermittent doses of
methamphetamine administered in the current study were likely not sufficient to cause
alterations in NET expression. The current results suggest early life stress and acute
methamphetamine administration in adulthood do not impact prefrontal cortex NET
expression long-term.
Finally, no significant changes were observed in the ventral midbrain for expression
of cocaine-amphetamine regulated transcript (CART). Few studies have examined
CART in relation to methamphetamine (Morio, Ujike, Nomura, et al., 2006) and, to date
no studies have reported CART expression after methamphetamine treatment. Previous
studies have examined CART in relation to cocaine and, to a lesser extent, amphetamine
administration (Douglass, McKinzie, & Couceyro, 1995; Vrang, Larsen, & Kristensen,
2002; Marie-Claire, Laurendeau, Canestrelli, Courtin, Vidaud, Roques, Noble, 2003).
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Variations in the pharmacological effects between amphetamine and methamphetamine
may account for variations in gene expression (Goodwin et al., 2009). Furthermore, the
effects of other psychostimulants on CART expression remain controversial. Originally,
increased expression of CART was found after high dose administration of cocaine and
amphetamine (Douglass, McKinzie, & Couceyro, 1995). Additional studies found CART
expression does not always increase after cocaine or amphetamine administration, even at
similar doses used by Douglass, McKinzie, and Couceyro (Vrang, Larsen, & Kristensen,
2002; Marie-Claire, Laurendeau, Canestrelli, Courtin, Vidaud, Roques, Noble, 2003).
The discrepancies among these findings may further be due to dosing patterns. Highdose binge patterns of cocaine administration leads to increased expression of CART
(Brenz Verca, Widmer, Wagner, Dreyer, 2001;Hunter, Vicentic, Rogge, & Kuhar, 2005).
The low dose used in the current study was likely not enough to cause a change in CART
expression. Future studies should look at CART expression in the context of a dosebinge pattern of methamphetamine administration.
Results of the current study suggest early life stress does not affect methamphetamine
conditioned place preference but may alter methamphetamine locomotor sensitivity in
males. Overlapping, but different brain systems likely mediate the effects of drug reward
and drug-induced locomotor activity (Koob & Le Moal, 1997; Kalivas & Stewart, 1991).
Conflicting findings among studies suggest the effects of early life stress on drug reward
and sensitivity are variable (Kikusui, Faccidomo, & Miczek, 2005; Matthews et al., 2004;
Vazquez et al., 2005). These inconsistent findings likely result from differences in drug
class, variations among early life stress procedures, and paradigm used to measure drug
reward and sensitivity.
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Based on the results of this study, it is suggested that early life stress alters
methamphetamine induced locomotor activity and does not influence methamphetamine
conditioned place preference reward. Additionally, this effect is more robust in males
compared to females.
Studies should further characterize the effects of methamphetamine sensitivity in
relations to early life stress and the possible mediating effects of sex. Additionally, it will
be important to model methamphetamine abuse patterns observed in the human
population, including binge dosing. Maternal separation has previously been shown to
alter neurotransmitter systems that are vulnerable to methamphetamine neurotoxicity
caused by binge dosing. Therefore, future studies should further examine the effect of
early life stress on sensitivity to methamphetamine neurotoxicity. These proposed future
studies will further characterize the effects of early life stress on methamphetamine
sensitivity. Clinically, this research will aid in targeting at risk populations and lead to
improved interventions and treatments.
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APPENDIX 1
SUPPLEMENTAL DATA
Table 1 Primer Sequences
Target
Rat
GAPDH

Forward Primer
5‟-CTCAACTACATGGTCTACATGTTCCA-3‟

Reverse Primer
5‟-CTTCCCATTCTCAGCCTTGACT-3‟

Rat DAT 5‟- TGACGCAGGAGTCAGTCGAAGAAGAA-3‟ 5‟-TTTAGCCGGGGCCACCACTGA-3‟
Rat NET 5‟-CAGCACCATCAACTGTGTTACC-3‟

5‟-AGGACCTGGAAGTCATCAGC-3‟

Rat CART 5‟-AGTCCCCATGTGTGACGTGGA-3‟

5‟GGAAATATGGGAACCGAAGGAGGC-3‟

Table 2 RT-PCR Results
Female
CMeth
PFC
9.55
N.Acc. 8.52
VTA
8.49

SMeth
10.34
10.69
8.32

SSaline
10.43
9.20
7.87

CSaline
9.80
8.24
8.07

Male
CMeth
10.25
9.57
7.77

SMeth
9.58
10.86
9.04

SSaline
10.56
10.07
7.62

CSaline
9.47
8.71
8.12

All genes were normalized to GAPDH and compared against the control group
(non separated, saline). No significant differences were found for NET (F(1, 36)
= 0.55, p>0.05), DAT (F(1, 35) = 0.70, p>0.05), or CART (F(1, 37) = 0.548,
p>0.05). Abbreviations: PFC (Prefrontal Cortex), N.Acc. (Nucleus Accumbens),
VTA (Ventral Tegmental Area), C (Control), S (Separated).
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Time Spent in Drug Paired Chamber on Day 10
1.2

†

Proportion Score

1
0.8
0.6
0.4
0.2
0
-0.2

Meth - MS

Meth - C

Saline - MS

Saline - C

-0.4

Male

Female

Figure 1
There was a significant effect for drug (F(1,72) = 14.45, p<0.001†) with
methamphetamine animals spending more time in the drug paired chamber.
There was not a significant effect condition (F(1,72) = 1.56, p>0.05) or sex
(F(1,72) = 0.830, p>0.05). There were no significant interactions for the time
spent in the drug paired chamber.
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Figure 2

Figure 3
Total ambulations for male (Figure 2) and female (Figure 3)
methamphetamine group across drug and saline days. For
methamphetamine days (circles) there was a significant effect of sex
(F(1, 33) = 11.43, p<0.001) with males (figure 2) exhibiting lower
locomotor activity compared to females (figure 3). Condition was
approaching significance (F(3, 33) = 3.57, p=0.068) with separated
animals (dashed line) exhibiting higher locomotor activity. There was
no sex x condition interaction (F(1, 33) = 0.054, p>0.05). For saline
days (squares) there was a significant effect of sex (F(1, 30) = 13.62,
p<0.01) with females exhibiting higher locomotor activity. There was
no effect of condition (F(1, 30) = 0.84, p>0.05). There were no
significant interactions.
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IACUC APPROVAL
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